The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Coherus BioSciences, Inc(NASDAQ:CHRS) 
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its product candidate pipeline...
Website: http://www.coherus.com
Founded: 2010
Full Time Employees: 306
Sector: Healthcare
Industry: Biotechnology
Coherus BioSciences Days Payable Outstanding ttm (DPO)
Coherus BioSciences Days Receivable Outstanding ttm (DSO)
Coherus BioSciences Days Inventory Outstanding ttm (DIO)
Coherus BioSciences Op Cashflow Per Share ttm
Coherus BioSciences Free Cashflow Per Share ttm
Coherus BioSciences Cash Per Share ttm
Coherus BioSciences P/S ratio ttm
Coherus BioSciences (GAAP) P/E ratio ttm
Coherus BioSciences P/B ratio ttm
No extra charts and metrics for this ticker.